Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone in neonates with persistent pulmonary hypertension of the newborn pilot trial
NL-OMON48755Withdrawn
- Sponsor
- RCSI Clinical Research Centre
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in persistent pulmonary hypertension of the newborn (PPHN) comparing Milrinone plus inhaled nitric oxide with Placebo plus inhaled nitric oxide (2 arms). Primary endpoints: Time on inhaled nitric oxide and Time on invasive ventilation. Planned start Sep 2019; status: withdrawn.
02
Drugs
milrinone
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NL-OMON48755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48755.